Campbell Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-71,512
| Closed | -$274K | – | 45 |
|
|
2020
Q1 | $274K | Sell |
71,512
-300
| -0.4% | -$1.15K | 0.28% | 28 |
|
|
2019
Q4 | $434K | Sell |
71,812
-38,639
| -35% | -$234K | 0.27% | 44 |
|
|
2019
Q3 | $835K | Buy |
110,451
+12,662
| +13% | +$95.7K | 0.62% | 33 |
|
|
2019
Q2 | $1.33M | Sell |
97,789
-82,998
| -46% | -$1.12M | 1.06% | 26 |
|
|
2019
Q1 | $980K | Buy |
180,787
+9,100
| +5% | +$49.3K | 0.71% | 31 |
|
|
2018
Q4 | $510K | Buy |
+171,687
| New | +$510K | 0.65% | 26 |
|